openPR Logo
Press release

Continuous Glucose Monitoring: The Current State of the Art | Abbott, Apple, Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp

05-04-2020 06:27 AM CET | Health & Medicine

Press release from: Continuous Glucose Monitoring Market

Continuous Glucose Monitoring (CGM) Market 2020

Continuous Glucose Monitoring (CGM) Market 2020

Recent research and the current scenario as well as future market potential of "Continuous Glucose Monitoring: The Current State of the Art".

This report is designed to investigate and discuss the latest developments in continuous glucose monitoring (CGM) for the management of diabetes. The study's goals include

Presenting the current products in the U.S., EU and elsewhere.
Looking at the technology--both on the market and in development.
Tracing improvements that companies are engineering and where these improvements may lead within the market.
Examining how close the industry is to a device-based artificial pancreas (AP).
Exploring selected clinical trials, the conclusions drawn from the research, and how the clinical trials affect the further development of CGM.

Get Free Sample Report of Continuous Glucose Monitoring Market & COVID-19 Impact Analysis @ https://decisionmarketreports.com/request-sample/1332608

Report Includes :

An overview of the current state of the art for Continuous Glucose Monitoring (CGM) for diabetes
Analyses of global market trends with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
Encompassing details of CGM functionalities like how they work, who can use one, and when a CGM could help to better manage the disease
Examination of the critical issues within the CGM market, including technological developments, geographic trends, market dynamics, adoption trends and clinical trials
Evaluation of current market size, market forecast and future of the CGM device industry
Market share analysis of the leading players of the industry and their comprehensive company profiles
Information on leading companies, including Abbott Labs, Apple Inc., Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp

Report Scope

The scope of this study includes what a CGM is, how it works and how a PWD wears the device. This study also includes advances in the technology--both those advances being seen in the market today and advances for which CE mark or FDA approval is pending. There is a section covering the pancreas and diabetes, including the continued growth in the number of diabetics and prediabetics in the U.S. and elsewhere. It covers selected clinical trials pertinent to the evolution and proliferation of CGMs. The scope of this report includes novel CGMs and components in development. These may or may not ever see market launch but should nonetheless be of interest to industry managers.

Also covered here are selected regulatory and reimbursement affairs. Regulatory guidelines need to keep abreast of the technological developments so that safe, effective devices may enter the market. Without sufficient, carefully crafted reimbursement or payer coverage, the devices will never get off the ground. Both favorable regulatory and reimbursement guidelines are needed if manufacturers are to continue to develop and commercialize the best equipment for managing diabetes.

Selected companies are profiled in this report. These include not only the market leaders--Dexcom, Medtronic, Abbott, Tandem and Insulet--but also smaller companies working on promising technology.

Not covered in the scope of this report is in-depth analysis of market values and growth rates. These are available in other BCC Research reports. Also not covered is the ultimate in artificial pancreas: the cell-based implant. While these are under development, for practical purposes implants seem to be some distance down the road.

If You Want Additional Information Or Specific Requirement About Impact of COVID-19 on Continuous Glucose Monitoring Market @ https://decisionmarketreports.com/request-customization/1332608

Contact Us :
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com
Market Info 24/7

About Us :
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Glucose Monitoring: The Current State of the Art | Abbott, Apple, Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp here

News-ID: 2032488 • Views:

More Releases from Continuous Glucose Monitoring Market

CONTINUOUS GLUCOSE MONITORING MARKET TO REACH US$ 1.02 BILLION BY 2024 : CMI
CONTINUOUS GLUCOSE MONITORING MARKET TO REACH US$ 1.02 BILLION BY 2024 : CMI
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. Get Free PDF Research Brochure for more
Continuous Glucose Monitoring Market to reach US$ 1.02 Billion by 2024
Continuous Glucose Monitoring Market to reach US$ 1.02 Billion by 2024
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. Get Free PDF Research Brochure for more

More Releases for CGM

Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
Canada Insulin Pump & CGM Industry 2018
Canada Insulin Pump & CGM Industry Although Canada insulin pump market is small but it has market potential to reach nearly CAD 1 Billion mark by the end of year 2024. Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
To study the market for CGM market in a precise manner, Market Research Hub (MRH) has included a new research report. The report is titled “Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast”, which enlightens the readers about the market share as well as growth rate during the period 2017-2022. The research study estimates that the CGM market sector
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
"The Report Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
Researchmoz added Most up-to-date research on "Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast" to its huge collection of research reports. Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2